Nonprofit · EIN 39-2445499
INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM
Tax-exempt · SANTA MONICA, CA 90403
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990-EZ | $60,289 | $3,755 | $56,534 | $56,534 | – | $56,534 |
Financial details: 990-EZ for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $60,289
Expenses
- Compensation of officers, directors and key employees
- $0
- Professional fees and payments to contractors
- $1,919
- Other expenses
- $1,836
Balance sheet and other
- Total assets, start of year
- $0
- Total assets, end of year
- $56,534
- Total liabilities, end of year
- –
- Net assets, end of year
- $56,534
- Cash, savings and investments
- $56,534
- Gross receipts
- $60,289
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990-EZ for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| SANT CHAWLA | CEO | 0.5 | $0 |
| ERLINDA GORDON | CFO | 1 | $0 |
| ANIA MORADKHANI | Secretary | 0.5 | $0 |
Address and contacts
- Address (IRS master file)
- 2811 WILSHIRE BLVD STE 420, SANTA MONICA, CA 90403-4810
- Signed the 990-EZ
- ERLINDA GORDON, CFO
- Phone
- (818) 726-3278
- Return prepared by
- Karis Accounting Inc
California records
California keeps its own records of charities and corporations. Search them by EIN 39-2445499 or by the name INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
THE ORGANIZATION'S MISSION IS TO EXPEDITE THE DEVELOPMENT OF IMMUNOTHERAPY PRODUCTS FOR CANCER AND OTHER UNMET MEDICAL NEEDS. THIS INCLUDES BASIC SCIENCE, TRANSLATIONAL AND CLINICAL RESEARCH, TREATMENT AND EDUCATION OF CANCER PATIENTS.
Program accomplishments
- THE ORGANIZATION WAS FORMED IN 2025. BEING THE INITIAL YEAR, THE ORGANIZATION WAS SETTING UP ITS PROGRAMS AND DID NOT YET HAVE ANY ACTIVE PROGRAM SERVICES IN PLACE DURING THE TAX YEAR.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990-EZ on file |
| 2024 | December 31, 2024 | May 15, 2025 | Check at the IRS |
| 2023 | December 31, 2023 | May 15, 2024 | Check at the IRS |
IRS record
- EIN
- 39-2445499
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2025
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H30)
- Assets (IRS master file)
- $56,534
- Income (IRS master file)
- $60,289
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990-EZ | December 2025 | $60,289 | $3,755 | $56,534 | XML |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 39-2445499).
Questions about INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM
- What is the EIN of INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM?
- The employer identification number (EIN) of INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM is 39-2445499.
- Is INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2025.
- Are donations to INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM last file with the IRS?
- The latest return in the IRS public files is the 990-EZ for the year ended December 2025.
- Who are the officers and directors of INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM?
- The 990-EZ for the year ended December 31, 2025 lists 3 people; 0 received compensation from the organization.
- How much revenue does INNOVATIVE IMMUNO-ONCOLOGY CONSORTIUM have?
- On its 990-EZ for the year ended December 31, 2025 it reported revenue of $60,289, expenses of $3,755 and total assets of $56,534 at year end.
Other nonprofits in SANTA MONICA
- MOVEMBER FOUNDATION EIN 77-0714052 · last filed 990 for 2026
- WINGS FOR LIFE USA - SPINAL CORD RESEARCH FOUNDATION INC EIN 81-4795399 · last filed 990 for 2025
- FOUNDATION FOR SPINAL RESTORATION EIN 46-1150250 · last filed 990 for 2024
- CALIFORNIA ONCOLOGY RESEARCH INSTITUTE INC EIN 42-1757010 · last filed 990 for 2024
- AVENI FOUNDATION EIN 83-0731767 · last filed 990 for 2025
- INSTITUTE OF REGENERATIVE AND CELLULAR MEDICINE EIN 32-0421125 · last filed 990-EZ for 2024
- FRIENDS OF OLIVER INC EIN 88-4248830 · last filed 990-EZ for 2024
- CHIARI PROJECT EIN 47-3348212 · last filed 990-N for 2025
All nonprofits in SANTA MONICA · California · Medical research